Drug class
Low-molecular-weight heparin (LMWH); antithrombin-dependent anticoagulant
Mechanism of action
Binds antithrombin and accelerates inhibition of coagulation factor Xa, with less activity against thrombin (factor IIa) than unfractionated heparin. This reduces fibrin formation and thrombus propagation.
General use cases
- Prevention of venous thromboembolism in surgical and medical patients at risk
- Treatment of deep-vein thrombosis and selected thromboembolic conditions, and use in unstable angina or non-Q-wave myocardial infarction where authorised; product indications vary by jurisdiction
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
